These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

671 related articles for article (PubMed ID: 28429737)

  • 1. The glutamate/cystine xCT antiporter antagonizes glutamine metabolism and reduces nutrient flexibility.
    Shin CS; Mishra P; Watrous JD; Carelli V; D'Aurelio M; Jain M; Chan DC
    Nat Commun; 2017 Apr; 8():15074. PubMed ID: 28429737
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression of xCT and activity of system xc(-) are regulated by NRF2 in human breast cancer cells in response to oxidative stress.
    Habib E; Linher-Melville K; Lin HX; Singh G
    Redox Biol; 2015 Aug; 5():33-42. PubMed ID: 25827424
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The glutamate/cystine antiporter SLC7A11/xCT enhances cancer cell dependency on glucose by exporting glutamate.
    Koppula P; Zhang Y; Shi J; Li W; Gan B
    J Biol Chem; 2017 Aug; 292(34):14240-14249. PubMed ID: 28630042
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Amino acid transporter SLC7A11/xCT at the crossroads of regulating redox homeostasis and nutrient dependency of cancer.
    Koppula P; Zhang Y; Zhuang L; Gan B
    Cancer Commun (Lond); 2018 Apr; 38(1):12. PubMed ID: 29764521
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Glutamate, excitatory amino acid transporters, Xc- antiporter, glutamine synthetase, and gamma-glutamyltranspeptidase in human corneal epithelium.
    Langford MP; Redmond P; Chanis R; Misra RP; Redens TB
    Curr Eye Res; 2010 Mar; 35(3):202-11. PubMed ID: 20373878
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification, Expression, and Roles of the Cystine/Glutamate Antiporter in Ocular Tissues.
    Martis RM; Knight LJ; Donaldson PJ; Lim JC
    Oxid Med Cell Longev; 2020; 2020():4594606. PubMed ID: 32655769
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The cystine/glutamate antiporter xCT is a key regulator of EphA2 S897 phosphorylation under glucose-limited conditions.
    Teramoto K; Katoh H
    Cell Signal; 2019 Oct; 62():109329. PubMed ID: 31152846
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Increased expression of cystine/glutamate antiporter in multiple sclerosis.
    Pampliega O; Domercq M; Soria FN; Villoslada P; Rodríguez-Antigüedad A; Matute C
    J Neuroinflammation; 2011 Jun; 8():63. PubMed ID: 21639880
    [TBL] [Abstract][Full Text] [Related]  

  • 9. ROS Mediate xCT-Dependent Cell Death in Human Breast Cancer Cells under Glucose Deprivation.
    Chen MC; Hsu LL; Wang SF; Hsu CY; Lee HC; Tseng LM
    Cells; 2020 Jul; 9(7):. PubMed ID: 32630312
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Oncogenic PI3K promotes methionine dependency in breast cancer cells through the cystine-glutamate antiporter xCT.
    Lien EC; Ghisolfi L; Geck RC; Asara JM; Toker A
    Sci Signal; 2017 Dec; 10(510):. PubMed ID: 29259101
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cystine transporter SLC7A11/xCT in cancer: ferroptosis, nutrient dependency, and cancer therapy.
    Koppula P; Zhuang L; Gan B
    Protein Cell; 2021 Aug; 12(8):599-620. PubMed ID: 33000412
    [TBL] [Abstract][Full Text] [Related]  

  • 12. mTORC2 Regulates Amino Acid Metabolism in Cancer by Phosphorylation of the Cystine-Glutamate Antiporter xCT.
    Gu Y; Albuquerque CP; Braas D; Zhang W; Villa GR; Bi J; Ikegami S; Masui K; Gini B; Yang H; Gahman TC; Shiau AK; Cloughesy TF; Christofk HR; Zhou H; Guan KL; Mischel PS
    Mol Cell; 2017 Jul; 67(1):128-138.e7. PubMed ID: 28648777
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A negative correlation between expression profiles of runt-related transcription factor-2 and cystine/glutamate antiporter xCT subunit in ovariectomized mouse bone.
    Uno K; Takarada T; Nakamura Y; Fujita H; Hinoi E; Yoneda Y
    J Pharmacol Sci; 2011; 115(3):309-19. PubMed ID: 21325781
    [TBL] [Abstract][Full Text] [Related]  

  • 14. xCT knockdown in human breast cancer cells delays onset of cancer-induced bone pain.
    Ungard RG; Linher-Melville K; Nashed MG; Sharma M; Wen J; Singh G
    Mol Pain; 2019; 15():1744806918822185. PubMed ID: 30799686
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cystine/glutamate antiporter xCT deficiency reduces metastasis without impairing immune system function in breast cancer mouse models.
    Ruiu R; Cossu C; Iacoviello A; Conti L; Bolli E; Ponzone L; Magri J; Rumandla A; Calautti E; Cavallo F
    J Exp Clin Cancer Res; 2023 Sep; 42(1):254. PubMed ID: 37770957
    [TBL] [Abstract][Full Text] [Related]  

  • 16. System Xc
    Wang M; Li B; Meng W; Chen Y; Liu H; Zhang Z; Li L
    Oral Dis; 2024 Jul; 30(5):2952-2964. PubMed ID: 37856618
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The x(c)(-) cystine/glutamate antiporter (xCT) as a potential target for therapy of cancer: yet another cytotoxic anticancer approach?
    Savaskan NE; Hahnen E; Eyüpoglu IY
    J Cell Physiol; 2009 Aug; 220(2):531-2; author reply 533-4. PubMed ID: 19415694
    [No Abstract]   [Full Text] [Related]  

  • 18. Functional interactions of the cystine/glutamate antiporter, CD44v and MUC1-C oncoprotein in triple-negative breast cancer cells.
    Hasegawa M; Takahashi H; Rajabi H; Alam M; Suzuki Y; Yin L; Tagde A; Maeda T; Hiraki M; Sukhatme VP; Kufe D
    Oncotarget; 2016 Mar; 7(11):11756-69. PubMed ID: 26930718
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Redox-dependent AMPK inactivation disrupts metabolic adaptation to glucose starvation in xCT-overexpressing cancer cells.
    Lee Y; Itahana Y; Ong CC; Itahana K
    J Cell Sci; 2022 Aug; 135(15):. PubMed ID: 35775474
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Changes in glutamate and glutamine distributions in the retinas of cystine/glutamate antiporter knockout mice.
    Knight LJ; Martis RM; Donaldson PJ; Acosta ML; Lim JC
    Mol Vis; 2023; 29():274-288. PubMed ID: 38222448
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 34.